Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders
Lisa Madden(CHRISTUS Transplant Institute), Shalini Shenoy(Washington University in St. Louis), Andrew L. Gilman(Gene Therapy Laboratory), Lisa Murray(Washington University in St. Louis), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Paul R. Haut(Indiana University Health), Sonali Chaudhury(Northwestern University), Dorothea Douglas(University of Arizona), Ka Wah Chan(Methodist Children’s Hospital), Michael A. Pulsipher(Primary Children's Hospital), Gregory A. Hale(Johns Hopkins University), Robert J. Hayashi(Washington University in St. Louis)
Cited by 54
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
|Journal of Clinical Oncology|2022|369